Press Releases

ALBUQUERQUE, N.M., July 11, 2019 /PRNewswire/ -- Lovelace Biomedical and Exemplar Genetics have teamed together to win a contract from the National Institutes of Health's National Center for the Advancement of Translational Sciences, for the study of Sickle Cell Disease (SCD).  SCD is an autosomal recessive disorder that affects a large number of African-Ameri

INDIANAPOLIS, July 11, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the New England Journal of Medicine published positive Phase 3 study results of Emgality® (galcanezumab-gnlm) for the treatment of episodic cluster headache.1 In this study, Emgality reduced the frequency of weekly clu

STOCKHOLM, July 11, 2019 /PRNewswire/ -- The James M. Slater, MD Proton Treatment and Research Center at Loma Linda University Medical Center, US, has chosen the treatment planning system (TPS) RayStation®* to replace its existing systems for photon and proton therapy planning, following a tender process. The James M. Slater

NEW YORK and TORONTO, July 11, 2019 /PRNewswire/ - CBD For Life (the "Company"), a subsidiary of

NEW YORK, July 11, 2019 /PRNewswire/ -- A new report from WebMD finds that while grief is nearly universal, most people feel rushed to "get over it," and find social media posts about their loss among the least helpful responses from others during the grieving process.

NEW YORK, July 11, 2019 /PRNewswire/ -- LabFinder.com, the convenient online platform for patients to schedule their laboratory and radiology tests and access test results, has announced an API i

EXTON, Pa., July 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that i

MONTGOMERY, Ala., July 11, 2019 /PRNewswire/ -- H2-Pharma, LLC, a privately held pharmaceutical company, announced today that it has entered into an agreement with CHEPLAPHARM Arzneimittel GmbH to be the exclusive U.S. distributor of ETOPOPHOS® (etoposide phosphate) for injection. This opportunity arose due to its successful partnership with CHEPLAPHARM Arzneimittel

PHILADELPHIA, July 11, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global healthcare company, today highlighted the first publication of National Comprehensive Cancer Network (NCCN) pediatric acute lymphoblastic leukemia (ALL)

SOUTH SAN FRANCISCO, Calif., July 11, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announces initiation of its Phase 1/2 study evaluating IDE196 in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions (ClinicalTrial